ASSEMBLY BIOSCIENCES, INC.

Analyst Reco. Assembly Biosciences, Inc.

Equities

ASMB

US0453962070

Market Closed - Nasdaq Other stock markets 01:30:00 25/06/2024 am IST			5-day change	1st Jan Change
15.7 ^USD	+0.38%		+3.56%	+59.53%

18/06	Assembly Biosciences, Inc. Doses First Participant in Phase 1B Clinical Trial Evaluating Next-Generation Capsid	CI
17/06	Assembly Biosciences, Inc. announced that it has received $2.77507 million in funding from Gilead Sciences, Inc.	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Adjusts Price Target on Assembly Biosciences to $1.50 From $2.50, Keeps Neutral Rating	24/23/24	MT
Mizuho Cuts Price Target on Assembly Biosciences to $3 From $14, Keeps Buy Rating	15/22/15	MT
Truist Securities Downgrades Assembly Biosciences to Hold From Buy, Adjusts Price Target to $2 From $11	24/22/24	MT
HC Wainwright Adjusts Assembly Biosciences Price Target to $2.50 From $3,50, Maintains Buy Rating	21/22/21	MT
Truist Securities Adjusts Assembly Biosciences Price Target to $12 From $15, Maintains Buy Rating	01/22/01	MT
ASSEMBLY BIOSCIENCES : HC Wainwright Starts Assembly Biosciences at Neutral with $3.50 Price Target	13/21/13	MT
ASSEMBLY BIOSCIENCES : William Blair Downgrades Assembly Biosciences to Market Perform From Outperform	02/21/02	MT
ASSEMBLY BIOSCIENCES : Mizuho Securities Adjusts Price Target on Assembly Biosciences to $14 From $13 on Lower Expenses, Reiterates Buy Rating	12/21/12	MT
ASSEMBLY BIOSCIENCES : SVB Leerink Adjusts Price Target for Assembly Biosciences to $7 From $8, Maintains Market Perform Rating	11/21/11	MT
ASSEMBLY BIOSCIENCES : SVB Leerink Downgrades Assembly Biosciences to Market Perform From Outperform, Adjusts PT to $8 From $9	23/21/23	MT
ASSEMBLY BIOSCIENCES : Jefferies Adjusts Price Target for Assembly Biosciences to $7 From $10, Maintains Hold Rating	21/20/21	MT
ASSEMBLY BIOSCIENCES : Mizuho Adjusts Assembly Biosciences' PT to $13 From $30 After H0731 'Failure in Finite Therapy;' Buy Rating Kept on Undervalued Chronic Suppressive Therapy	04/20/04	MT
ASSEMBLY BIOSCIENCES : Jefferies Downgrades Assembly Biosciences to Hold From Buy; Price Target is $10	06/20/06	MT
Assembly Biosciences, Inc. Announces Results from Research Study Evaluating the Turnover Rate of Covalently Closed Circular DNA, Which Plays Pivotal Role in the Establishment and Persistence of HBV Infection	06/20/06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer